Curran Terrie 4
4 · Phathom Pharmaceuticals, Inc. · Filed Jan 22, 2024
Insider Transaction Report
Form 4
Curran Terrie
DirectorPresident and Chief Executive
Transactions
- Award
Stock Option (Right to Buy)
2024-01-18+475,000→ 475,000 totalExercise: $7.60Exp: 2034-01-17→ Common Stock (475,000 underlying)
Footnotes (1)
- [F1]The stock option will vest with respect to 25% of the shares of common stock on January 18, 2025, and will vest with respect to the remaining shares in equal monthly installments over the following three years, subject to the reporting person's continuous service to the Company on the applicable vesting dates.